• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Life sciences vehicle announces fund close
Vesalius Biocapital holds €65m first close for third fund

Vesalius Biocapital III will accept new investors on a "rolling closing" basis until final close

  • Funds
  • 18 May 2017
Dental products and whitening services
Vendis Capital invests in Sylphar

Transaction marks the sixth investment made from Vendis Capital II, closed on €180m in May last year

  • Buyouts
  • 16 May 2017
Coronary medicine
LSP leads €15m series-A for Cardior Pharmaceuticals

New funding will allow the company to develop its lead compound, which targets RNAs linked to heart failure

  • Early-stage
  • 12 May 2017
Biotechnology
HTGF et al. invest in Numaferm

European Investment Fund and angel investors also participated in the seed funding round

  • DACH
  • 12 May 2017
Clinical trials and biotechnology
PAI enters exclusivity with Ergon for EliTech SBO

Ergon bought the medical equipment maker in 2010 in a deal valued at more than €100m

  • Buyouts
  • 12 May 2017
Nurses and other healthcare staff
Gimv acquires stake in MVZ Holding

Gimv will provide financial and strategic support for MVZ Holding’s growth and acquisition strategy

  • Expansion
  • 10 May 2017
Finding a cure
Apposite Capital leads €7m round for NIMGenetics

Deal is the third acquisition for the GP's 2016-vintage vehicle, Apposite Healthcare Fund II

  • Buyouts
  • 10 May 2017
Laboratory equipment and furnishings
EMBL and Life Sciences Partners sell Luxendo to Bruker

Bruker will expand its portfolio with the addition of Luxendo's microscopes and intellectual property

  • Exits
  • 09 May 2017
Blood samples and other clinical trial materials
Novartis, Columbus et al. in €37.5m series-A round for Vivet

Other investors in the round include Roche Venture Fund, HealthCap, Kurma Partners and Ysios Capital

  • Early-stage
  • 04 May 2017
Biotechnology and medical sciences
BIVF at al. lead €20m series-A for ImCheck Therapeutics

Backers include Kurma Partners, Idinvest, Gimv and Life Sciences Partners

  • Early-stage
  • 03 May 2017
DACH healthcare deal activity
Shot in the arm for DACH healthcare market

Consolidation opportunities in the mid-market fuel increased investment from private equity, with aggregate volume reaching a six-year high

  • DACH
  • 03 May 2017
Elderly healthcare and nursing homes
Eurazeo sells Colisée to IK Investment Partners

Sale follows a three-year tenure and reportedly values the care home operator at €236m

  • Buyouts
  • 28 April 2017
Laboratory blood and DNA testing
B&M Gates and VCs hold $45.5m series-D for Arsanis

New funding will be used to focus efforts on a phase II study for the prevention of pneumonia

  • Early-stage
  • 27 April 2017
Biotechnology and pharmaceuticals
Bain and Cinven publish Stada offer document

Offer values company at €5.3bn, the largest PE-backed takeover bid ever launched in Germany

  • Buyouts
  • 27 April 2017
Clinical trials and biotechnology
HTGF and IFH back KSK Diagnostics

New funding will be used to develop point-of-care tests by utilising isothermal amplification technology

  • Early-stage
  • 25 April 2017
Laser eye surgery
AGIC acquires laser manufacturer Fotona

Fotona will use the new funding and local support from AGIC to expand its sales effort in Asia

  • Buyouts
  • 24 April 2017
Life sciences vehicle announces fund close
Advent France Biotechnology holds €64.75m first close

Firm was launched in 2016 and targets early-stage companies in the life sciences sector

  • Venture
  • 20 April 2017
Mental health clinics and rehabilitation centres
BC's Elysium acquires Badby from Patron

BC Partners bought 22 mental health facilities in the UK, formerly part of Priory Group, in November

  • Exits
  • 18 April 2017
Microscopes and laboratory equipment
Cinven backed Synlab raises €250m via capital increase

Cinven will remain the majority shareholder of Synlab and other LP will retain its current stake

  • Expansion
  • 13 April 2017
Biotechnology and pharmaceuticals
Deal in Focus: Bain and Cinven to take Stada private

Acquisition of German pharmaceutical company would be the largest buyout ever recorded in the country

  • Investments
  • 13 April 2017
Doctor holding artificial heart valve
HTGF et al. sell Symetis to Boston Scientific for $435m

Companies have developed complementary heart valve technologies

  • Exits
  • 12 April 2017
Pharmacies and prescription services
Bain and Cinven to take Stada private

Offer of €66 per share values the German pharmaceutical company at €5.3bn EV

  • Buyouts
  • 10 April 2017
Healthcare and rehabilitation
Waterland’s Atos bolts on Orthoparc

Acquisition will increase Atos's number of beds by 20%, raising the total to more than 300

  • Portfolio management
  • 06 April 2017
hospital-doctors-web
CVC buys Metropolitan Hospital Group

GP injected capital from its 2013-vintage CVC Fund VI, which held a €10.5bn final close

  • Buyouts
  • 05 April 2017
62 63 64
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013